Linked Life Data

Renese (Tablet)

Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/2874

Statements in which the resource exists.
SubjectPredicateObjectContext
dailymed-drugs:2874rdf:typehttp://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:2874rdf:typedailymed-instance:drugslld:dailymed
dailymed-drugs:2874rdfs:labelRenese (Tablet)lld:dailymed
dailymed-drugs:2874dailymed-instance:dosageTherapy should be individualized according to patient response. This therapy should be titrated to gain maximal therapeutic response as well as the minimal dose possible to maintain that therapeutic response. The usual dosage of Renese tablets for diuretic therapy is 1 to 4 mg daily, and for antihypertensive therapy is 2 to 4 mg daily.lld:dailymed
dailymed-drugs:2874dailymed-instance:descripti...Renese is designated generically as polythiazide, and chemically as 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-, 1,1-dioxide. It is a white crystalline substance, insoluble in water but readily soluble in alkaline solution. Inert Ingredients: dibasic calcium phosphate; lactose; magnesium stearate; polyethylene glycol; sodium lauryl sulfate; starch; vanillin. The 2 mg tablets also contain: Yellow 6; Yellow 10.lld:dailymed
dailymed-drugs:2874dailymed-instance:activeIng...dailymed-ingredient:polythi...lld:dailymed
dailymed-drugs:2874dailymed-instance:contraind...Anuria. Hypersensitivity to this or other sulfonamide derived drugs.lld:dailymed
dailymed-drugs:2874dailymed-instance:supplyRENESE (polythiazide) Tablets are available as: 1 mg white, scored tablets in bottles of 100 (NDC 0069-3750-66). 2 mg yellow, scored tablets in bottles of 100 (NDC 0069-3760-66). 4 mg white, scored tablets in bottles of 100 (NDC 0069-3770-66).lld:dailymed
dailymed-drugs:2874dailymed-instance:genericDr...http://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:2874dailymed-instance:activeMoi...dailymed-ingredient:polythi...lld:dailymed
dailymed-drugs:2874dailymed-instance:inactiveI...dailymed-ingredient:lactoselld:dailymed
dailymed-drugs:2874dailymed-instance:inactiveI...dailymed-ingredient:magnesi...lld:dailymed
dailymed-drugs:2874dailymed-instance:inactiveI...dailymed-ingredient:starchlld:dailymed
dailymed-drugs:2874dailymed-instance:inactiveI...dailymed-ingredient:polyeth...lld:dailymed
dailymed-drugs:2874dailymed-instance:inactiveI...dailymed-ingredient:sodium_...lld:dailymed
dailymed-drugs:2874dailymed-instance:inactiveI...dailymed-ingredient:vanilli...lld:dailymed
dailymed-drugs:2874dailymed-instance:inactiveI...dailymed-ingredient:dibasic...lld:dailymed
dailymed-drugs:2874dailymed-instance:possibleD...diseasome-diseases:447lld:dailymed
dailymed-drugs:2874dailymed-instance:possibleD...diseasome-diseases:2455lld:dailymed
dailymed-drugs:2874dailymed-instance:precautio...Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals. All patients receiving thiazide therapy should be observed for clinical signs of fluid or electrolyte imbalance; namely, hyponatremia, hypochloremic alkalosis, and hypokalemia. Serum and urine electrolyte determinations are particularly important when the patient is vomiting excessively or receiving parenteral fluids. Medication such as digitalis may also influence serum electrolytes. Warning signs, irrespective of cause, are: dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances such as nausea and vomiting. Hypokalemia may develop with thiazides as with any other potent diuretic, especially with brisk diuresis, when severe cirrhosis is present, or during concomitant use of corticosteroids or ACTH. Interference with adequate oral electrolyte intake will also contribute to hypokalemia. Digitalis therapy may exaggerate metabolic effects of hypokalemia especially with reference to myocardial activity. Any chloride deficit is generally mild and usually does not require specific treatment except under extraordinary circumstances (as in liver disease or renal disease). Dilutional hyponatremia may occur in edematous patients in hot weather; appropriate therapy is water restriction, rather than administration of salt except in rare instances when the hyponatremia is life threatening. In actual salt depletion, appropriate replacement is the therapy of choice. Hyperuricemia may occur or frank gout may be precipitated in certain patients receiving thiazide therapy. Insulin requirements in diabetic patients may be increased, decreased, or unchanged. Latent diabetes mellitus may become manifest during thiazide administration. Thiazide drugs may increase the responsiveness to tubocurarine. The antihypertensive effects of the drug may be enhanced in the postsympathectomy patient. Thiazides may decrease arterial responsiveness to norepinephrine. This diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use. If progressive renal impairment becomes evident, as indicated by a rising nonprotein nitrogen or blood urea nitrogen, a careful reappraisal of therapy is necessary with consideration given to withholding or discontinuing diuretic therapy. Thiazides may decrease serum PBI levels without signs of thyroid disturbance.<br/>Pediatric Use: Safety and effectiveness in pediatric patients have not been established.lld:dailymed
dailymed-drugs:2874dailymed-instance:genericMe...polythiazidelld:dailymed
dailymed-drugs:2874dailymed-instance:fullNameRenese (Tablet)lld:dailymed
dailymed-drugs:2874dailymed-instance:adverseRe...A. GASTROINTESTINAL SYSTEM REACTIONS:<br/>B. CENTRAL NERVOUS SYSTEM REACTIONS:<br/>C. HEMATOLOGIC REACTIONS:<br/>D. DERMATOLOGIC���HYPERSENSITIVITY REACTIONS:<br/>E. CARDIOVASCULAR REACTION: Orthostatic hypotension may occur and may be aggravated by alcohol, barbiturates or narcotics.<br/>F. OTHER: Whenever adverse reactions are moderate or severe, thiazide dosage should be reduced or therapy withdrawn.lld:dailymed
dailymed-drugs:2874dailymed-instance:represent...http://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:2874dailymed-instance:routeOfAd...http://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:2874dailymed-instance:nameReneselld:dailymed
http://www4.wiwiss.fu-berli...dailymed-instance:producesD...dailymed-drugs:2874lld:dailymed
diseasome-diseases:447diseasome-instance:possible...dailymed-drugs:2874lld:diseasome
diseasome-diseases:2455diseasome-instance:possible...dailymed-drugs:2874lld:diseasome